Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Linezolid (1200mg) Tablet
Therapeutic Category
Antibacterials, Antibiotic
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Linzoglad 1200 Tablet (Linezolid 1200mg) is a premium, high-profit super-specialty product built for our PCD Pharma Franchise partners.
This high-strength Oxazolidinone antibiotic is a critical line of defense for treating severe infections caused by drug-resistant bacteria like MRSA and VRE. This product is essential in the ICU and Critical Care environment, guaranteeing stable, consistent institutional demand.
Why Linzoglad 1200 is Your Key to Profit:
Critical, Consistent Demand: As an established, last-resort treatment for life-threatening resistant infections, the need for Linezolid in hospitals and specialty clinics is constant, ensuring stable, high-volume revenue.
Maximum Specialty Margin: Positioned in the highest value antibiotic segment, this product commands premium pricing and secures some of the highest profit margins within critical care pharmaceuticals.
Consultant Loyalty: The clinical necessity of Linezolid for drug-resistant cases builds strong, reliable prescription loyalty from leading consultants and hospital drug committees.
Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition in your designated critical care and institutional network. Partner with us for full technical marketing support to secure high-value prescriptions and guaranteed business growth.
Contact us today to capture this max-margin critical care segment!
Common side effects may include nausea, vomiting, diarrhea, headache, or dizziness. Prolonged use may lead to bone marrow suppression, anemia, thrombocytopenia, or neuropathy. Rarely, patients may experience allergic reactions. Regular blood monitoring is recommended during therapy to detect hematological side effects early.
Linzoglad 1200 Tablet is indicated for the treatment of serious infections caused by susceptible Gram-positive bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), pneumonia, complicated skin and soft tissue infections, and sepsis. It is used in cases where other antibiotics may not be effective.
Take Linzoglad 1200 Tablet exactly as prescribed by your healthcare provider. Do not skip doses or stop treatment prematurely, even if symptoms improve, to prevent bacterial resistance. Inform your doctor about any pre-existing blood disorders, kidney or liver issues, or concurrent medications, particularly serotonergic drugs or monoamine oxidase inhibitors (MAOIs).
Store Linzoglad 1200 Tablet in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep the tablets in their original container and out of reach of children. Do not use the medication after the expiry date.
Composition : Linezolid (600mg)
Composition : Linezolid Intravenous Infusion I.P. 2mg Infusion
Composition : Linezolid I.P. 100mg Dry Syrup
Composition : Linezolid (600mg) Tablet
Composition : Aceclofenac (100mg) + Paracetamol (325mg) + Tolperisone (150mg)
Composition : Aceclofenac (100mg) + Thiocolchicoside (8mg) Tablet
Composition : Aceclofenac (100mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Linezolid is a powerful antibiotic used for serious bacterial infections, especially drug-resistant infections such as MRSA, pneumonia, skin and soft tissue infections, and hospital-acquired infections. It is a strong hospital-based anti-infective segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in hospitals, ICUs, and specialty clinics. It is widely used in critical infection management, ensuring strong institutional prescriptions and steady high-value orders.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for anti-infective and critical care formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from hospital procurement, ICU demand, critical infection treatment needs, and strong prescription-based turnover when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this anti-infective formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, product availability, and distribution support services.